Skip to main content
. 2018 Sep 12;33(3):612–624. doi: 10.1038/s41375-018-0253-3

Fig. 3.

Fig. 3

Mutational spectrum in human MLL-AML (N = 168). A frequency of mutations (%) was shown in each affected leukemogenic pathway